ArticleBMC psychiatry2025
Neuroendocrine abnormalities as predictors of suicidal ideation in bipolar disorder patients during depressive episodes: a cross-sectional study.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Bipolar disorder (BD) is a psychiatric disorder with a high prevalence of suicidal ideation (SI). While the relationship between BD and the endocrine system is well established, the influence of neuroendocrine hormones on SI during depressive episodes remains poorly understood. This cross-sectional study aimed to identify high-risk neuroendocrine factors for SI and evaluate their predictive efficacy using machine learning techniques. Data were obtained from the electronic medical records of patients hospitalized for BD depressive episodes at The First Affiliated Hospital of Jinan University in Guangzhou, Guangdong Province, China between January 1, 2017, and October 31, 2022. Of 635 eligible patients, 380 exhibited SI. In the multivariate analysis, lower levels of FT4 (OR = 0.925; 95% CI = 0.869–0.986; P = 0.017) and testosterone (OR = 0.799; 95% CI = 0.642–0.993; P = 0.043) were significantly associated with an increased risk of SI. Additionally, an earlier age of onset (OR = 0.936; 95% CI = 0.897–0.977; P = 0.002) and the presence of psychotic symptoms contributed to a higher risk of SI. Furthermore, we developed a supervised learning model—Naive Bayes classifier. The model identified age of onset as a key predictor of SI during depressive episodes of BD, highlighting its importance as the most relevant predictive variable for distinguishing patients at risk of SI. These findings could help clinicians more accurately identify BD patients with higher suicide risk, thereby improving diagnostic sensitivity for this disorder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.